Evidence map›Paper›PMID 40410772›Full record

ArticleJournal of orthopaedic surgery and research2025

Oxidized regenerated cellulose powder reduces perioperative bleeding and thigh swelling in total hip arthroplasty: a prospective interventional study.

Hisatoshi Ishikura, Toru Nishiwaki, Sho Fujita, Yuji Masuyama, Masaki Hatano, Takeyuki Tanaka, Sakae Tanaka

Abstract read
In one paragraph

Article in Journal of orthopaedic surgery and research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Patient Blood Management in Pediatric Patients: Current Strategies and Future PerspectivesTurkish journal of haematology : official journal of Turkish Society of Haematology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hisatoshi IshikuraDepartment of Orthopaedic Surgery, Shizuoka Red Cross Hospital, 8-2 Oitecho, Aoi- ku, Shizuoka city, 420-0853, Shizuoka, Japan. hishikura817@gmail.com.
Toru NishiwakiDepartment of Orthopaedic Surgery, Shizuoka Red Cross Hospital, 8-2 Oitecho, Aoi- ku, Shizuoka city, 420-0853, Shizuoka, Japan.
Sho FujitaDepartment of Orthopaedic Surgery, Shizuoka Red Cross Hospital, 8-2 Oitecho, Aoi- ku, Shizuoka city, 420-0853, Shizuoka, Japan.
Yuji MasuyamaDepartment of Orthopaedic Surgery, Shizuoka Red Cross Hospital, 8-2 Oitecho, Aoi- ku, Shizuoka city, 420-0853, Shizuoka, Japan.
Masaki HatanoDepartment of Orthopaedic Surgery, The University of Tokyo, Tokyo, 113-8655, Japan.
Takeyuki TanakaDepartment of Orthopaedic Surgery, The University of Tokyo, Tokyo, 113-8655, Japan.
Sakae TanakaDepartment of Orthopaedic Surgery, The University of Tokyo, Tokyo, 113-8655, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTotal hip arthroplasty (THA) is an effective treatment for hip osteoarthritis; however, perioperative blood loss and postoperative thigh swelling are significant challenges that can delay recovery and increase patient discomfort. Minimally invasive THA and pharmacological interventions, such as tranexamic acid, have mitigated some complications; however, achieving localized hemostasis, particularly in cancellous bones, remains problematic. We aimed to evaluate the efficacy of oxidized regenerated cellulose (ORC) powder in reducing perioperative blood loss and postoperative thigh swelling following THA.

methodsThis prospective interventional study included 152 patients who underwent primary unilateral THA via the direct anterior approach. The patients were divided into ORC (n = 74) and non-ORC (n = 78) groups. ORC powder was applied to three critical surgical sites: the acetabulum, femoral medullary canal, and the surrounding soft tissue. The estimated total blood loss (eTBL), postoperative blood loss (ePBL), thigh swelling, and hematologic parameters (hemoglobin, hematocrit, D-dimer, creatine kinase, and C-reactive protein) were assessed. Clinical outcomes were evaluated using the modified Harris Hip Score (mHHS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), and University of California, Los Angeles (UCLA) activity score at 3 months postoperatively.

resultsThe ORC group exhibited significantly lower eTBL and ePBL, smaller reductions in hemoglobin levels, and higher hematocrit levels up to postoperative day 7. Postoperative thigh swelling was significantly reduced in the ORC group, particularly on day 1, with a trend toward reduced swelling at all time points. However, there were no significant differences in the clinical scores between the groups at 3 months postoperatively.

conclusionsThe ORC powder application during THA effectively reduced perioperative blood loss and postoperative thigh swelling. Powdered ORC has the potential to maximize efficacy in THA because of its ability to be applied to hemispherical acetabular surfaces and deep femoral medullary canals, effectively addressing bleeding from both soft tissue and cancellous bone.

trial registrationThis prospective interventional study was reviewed and approved by the Ethics Committee of Shizuoka Red Cross Hospital (Approval No: 2023-36) and was designed and conducted according to the rules of the Declaration of Helsinki. Written informed consent was obtained from patients or their families.

Indexed as

Arthroplasty, Replacement, HipBlood Loss, SurgicalCellulose, OxidizedEdemaPostoperative HemorrhageThighAgedFemaleHumansMaleMiddle AgedPowdersProspective StudiesTreatment OutcomeCellulose, OxidizedPowdersBleedingOxidized regenerated celluloseSwellThigh swellingTotal hip arthroplasty

Identifiers

PMID40410772
PMCPMC12102834

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.